415 related articles for article (PubMed ID: 21471202)
1. Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function.
Leupin O; Piters E; Halleux C; Hu S; Kramer I; Morvan F; Bouwmeester T; Schirle M; Bueno-Lozano M; Fuentes FJ; Itin PH; Boudin E; de Freitas F; Jennes K; Brannetti B; Charara N; Ebersbach H; Geisse S; Lu CX; Bauer A; Van Hul W; Kneissel M
J Biol Chem; 2011 Jun; 286(22):19489-500. PubMed ID: 21471202
[TBL] [Abstract][Full Text] [Related]
2. A Novel Domain-Specific Mutation in a Sclerosteosis Patient Suggests a Role of LRP4 as an Anchor for Sclerostin in Human Bone.
Fijalkowski I; Geets E; Steenackers E; Van Hoof V; Ramos FJ; Mortier G; Fortuna AM; Van Hul W; Boudin E
J Bone Miner Res; 2016 Apr; 31(4):874-81. PubMed ID: 26751728
[TBL] [Abstract][Full Text] [Related]
3. Lrp4, a novel receptor for Dickkopf 1 and sclerostin, is expressed by osteoblasts and regulates bone growth and turnover in vivo.
Choi HY; Dieckmann M; Herz J; Niemeier A
PLoS One; 2009 Nov; 4(11):e7930. PubMed ID: 19936252
[TBL] [Abstract][Full Text] [Related]
4. Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels.
Chang MK; Kramer I; Huber T; Kinzel B; Guth-Gundel S; Leupin O; Kneissel M
Proc Natl Acad Sci U S A; 2014 Dec; 111(48):E5187-95. PubMed ID: 25404300
[TBL] [Abstract][Full Text] [Related]
5. Competitive blocking of LRP4-sclerostin binding interface strongly promotes bone anabolic functions.
Katchkovsky S; Chatterjee B; Abramovitch-Dahan CV; Papo N; Levaot N
Cell Mol Life Sci; 2022 Jan; 79(2):113. PubMed ID: 35099616
[TBL] [Abstract][Full Text] [Related]
6. Modulation of sclerostin expression by mechanical loading and bone morphogenetic proteins in osteogenic cells.
Papanicolaou SE; Phipps RJ; Fyhrie DP; Genetos DC
Biorheology; 2009; 46(5):389-99. PubMed ID: 19940355
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the interaction of sclerostin with the low density lipoprotein receptor-related protein (LRP) family of Wnt co-receptors.
Holdsworth G; Slocombe P; Doyle C; Sweeney B; Veverka V; Le Riche K; Franklin RJ; Compson J; Brookings D; Turner J; Kennedy J; Garlish R; Shi J; Newnham L; McMillan D; Muzylak M; Carr MD; Henry AJ; Ceska T; Robinson MK
J Biol Chem; 2012 Aug; 287(32):26464-77. PubMed ID: 22696217
[TBL] [Abstract][Full Text] [Related]
8. Sclerostin binds to LRP5/6 and antagonizes canonical Wnt signaling.
Li X; Zhang Y; Kang H; Liu W; Liu P; Zhang J; Harris SE; Wu D
J Biol Chem; 2005 May; 280(20):19883-7. PubMed ID: 15778503
[TBL] [Abstract][Full Text] [Related]
9. Mechanical stimulation of bone in vivo reduces osteocyte expression of Sost/sclerostin.
Robling AG; Niziolek PJ; Baldridge LA; Condon KW; Allen MR; Alam I; Mantila SM; Gluhak-Heinrich J; Bellido TM; Harris SE; Turner CH
J Biol Chem; 2008 Feb; 283(9):5866-75. PubMed ID: 18089564
[TBL] [Abstract][Full Text] [Related]
10. Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption.
Xiong L; Jung JU; Wu H; Xia WF; Pan JX; Shen C; Mei L; Xiong WC
Proc Natl Acad Sci U S A; 2015 Mar; 112(11):3487-92. PubMed ID: 25733894
[TBL] [Abstract][Full Text] [Related]
11. Lrp4 expression by adipocytes and osteoblasts differentially impacts sclerostin's endocrine effects on body composition and glucose metabolism.
Kim SP; Da H; Li Z; Kushwaha P; Beil C; Mei L; Xiong WC; Wolfgang MJ; Clemens TL; Riddle RC
J Biol Chem; 2019 Apr; 294(17):6899-6911. PubMed ID: 30842262
[TBL] [Abstract][Full Text] [Related]
12. An Akt-dependent increase in canonical Wnt signaling and a decrease in sclerostin protein levels are involved in strontium ranelate-induced osteogenic effects in human osteoblasts.
Rybchyn MS; Slater M; Conigrave AD; Mason RS
J Biol Chem; 2011 Jul; 286(27):23771-9. PubMed ID: 21566129
[TBL] [Abstract][Full Text] [Related]
13. Lrp4 and Wise interplay controls the formation and patterning of mammary and other skin appendage placodes by modulating Wnt signaling.
Ahn Y; Sims C; Logue JM; Weatherbee SD; Krumlauf R
Development; 2013 Feb; 140(3):583-93. PubMed ID: 23293290
[TBL] [Abstract][Full Text] [Related]
14. Sclerostin regulates release of bone mineral by osteocytes by induction of carbonic anhydrase 2.
Kogawa M; Wijenayaka AR; Ormsby RT; Thomas GP; Anderson PH; Bonewald LF; Findlay DM; Atkins GJ
J Bone Miner Res; 2013 Dec; 28(12):2436-48. PubMed ID: 23737439
[TBL] [Abstract][Full Text] [Related]
15. An Additional Lrp4 High Bone Mass Mutation Mitigates the Sost-Knockout Phenotype in Mice by Increasing Bone Remodeling.
Hendrickx G; Boudin E; Mateiu L; Yorgan TA; Steenackers E; Kneissel M; Kramer I; Mortier G; Schinke T; Van Hul W
Calcif Tissue Int; 2024 Feb; 114(2):171-181. PubMed ID: 38051321
[TBL] [Abstract][Full Text] [Related]
16. Multiple modes of Lrp4 function in modulation of Wnt/β-catenin signaling during tooth development.
Ahn Y; Sims C; Murray MJ; Kuhlmann PK; Fuentes-Antrás J; Weatherbee SD; Krumlauf R
Development; 2017 Aug; 144(15):2824-2836. PubMed ID: 28694256
[TBL] [Abstract][Full Text] [Related]
17. Sclerostin and the regulation of bone formation: Effects in hip osteoarthritis and femoral neck fracture.
Power J; Poole KE; van Bezooijen R; Doube M; Caballero-Alías AM; Lowik C; Papapoulos S; Reeve J; Loveridge N
J Bone Miner Res; 2010 Aug; 25(8):1867-76. PubMed ID: 20200987
[TBL] [Abstract][Full Text] [Related]
18. LRP4 association to bone properties and fracture and interaction with genes in the Wnt- and BMP signaling pathways.
Kumar J; Swanberg M; McGuigan F; Callreus M; Gerdhem P; Akesson K
Bone; 2011 Sep; 49(3):343-8. PubMed ID: 21645651
[TBL] [Abstract][Full Text] [Related]
19. Sclerostin: current knowledge and future perspectives.
Moester MJ; Papapoulos SE; Löwik CW; van Bezooijen RL
Calcif Tissue Int; 2010 Aug; 87(2):99-107. PubMed ID: 20473488
[TBL] [Abstract][Full Text] [Related]
20. Pigment epithelium-derived factor (PEDF) reduced expression and synthesis of SOST/sclerostin in bone explant cultures: implication of PEDF-osteocyte gene regulation in vivo.
Li F; Cain JD; Tombran-Tink J; Niyibizi C
J Bone Miner Metab; 2019 Sep; 37(5):773-779. PubMed ID: 30607618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]